Literature DB >> 15845519

CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.

Rosa M Andrade1, Jose-Andres C Portillo, Matthew Wessendarp, Carlos S Subauste.   

Abstract

Gamma interferon (IFN-gamma) is the major inducer of classical activation of macrophages. Classically activated mouse macrophages acquire antimicrobial activity that is largely dependent on the production of reactive nitrogen intermediates. However, protection against important intracellular pathogens can take place in the absence of IFN-gamma and nitric oxide synthase 2 (NOS2). Using Toxoplasma gondii as a model, we investigated if CD40 signaling generates mouse macrophages with effector function against an intracellular pathogen despite the absence of priming with IFN-gamma and lack of production of reactive nitrogen intermediates. CD40-stimulated macrophages acquired anti-T. gondii activity that was not inhibited by a neutralizing anti-IFN-gamma monoclonal antibody but was ablated by the neutralization of tumor necrosis factor alpha (TNF-alpha). Moreover, while the induction of anti-T. gondii activity in response to CD40 stimulation was unimpaired in macrophages from IFN-gamma(-/-) mice, macrophages from TNF receptor 1/2(-/-) mice failed to respond to CD40 engagement. In contrast to IFN-gamma-lipopolysaccharide, CD40 stimulation did not induce NOS2 expression and did not trigger production of reactive nitrogen intermediates. Neither N(G)-monomethyl-l-arginine nor diphenyleneiodonium chloride affected the induction of anti-T. gondii activity in response to CD40. Finally, macrophages from NOS2(-/-) mice acquired anti-T. gondii activity in response to CD40 stimulation that was similar to that of macrophages from wild-type mice. These results demonstrate that CD40 induces the antimicrobial activity of macrophages against an intracellular pathogen despite the lack of two central features of classically activated macrophages: priming with IFN-gamma and production of reactive nitrogen intermediates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845519      PMCID: PMC1087328          DOI: 10.1128/IAI.73.5.3115-3123.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

Review 1.  Regulation of biosynthesis of nitric oxide.

Authors:  C Nathan; Q W Xie
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

2.  IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.

Authors:  J A Langermans; M E Van der Hulst; P H Nibbering; P S Hiemstra; L Fransen; R Van Furth
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

3.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.

Authors:  A Svetić; F D Finkelman; Y C Jian; C W Dieffenbach; D E Scott; K F McCarthy; A D Steinberg; W C Gause
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

4.  Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs.

Authors:  D J Stuehr; O A Fasehun; N S Kwon; S S Gross; J A Gonzalez; R Levi; C F Nathan
Journal:  FASEB J       Date:  1991-01       Impact factor: 5.191

5.  Nitric oxide produced during murine listeriosis is protective.

Authors:  K S Boockvar; D L Granger; R M Poston; M Maybodi; M K Washington; J B Hibbs; R L Kurlander
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

6.  Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes.

Authors:  K P Beckerman; H W Rogers; J A Corbett; R D Schreiber; M L McDaniel; E R Unanue
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

7.  Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro.

Authors:  G N Vespa; F Q Cunha; J S Silva
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.

Authors:  Y Vodovotz; C Bogdan; J Paik; Q W Xie; C Nathan
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

9.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide.

Authors:  Q W Xie; R Whisnant; C Nathan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

Authors:  S Stenger; H Thüring; M Röllinghoff; C Bogdan
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  25 in total

1.  A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages.

Authors:  Dana G Mordue; Casey F Scott-Weathers; Crystal M Tobin; Laura J Knoll
Journal:  Mol Microbiol       Date:  2006-12-11       Impact factor: 3.501

2.  CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes.

Authors:  Rosa M Andrade; Matthew Wessendarp; Marc-Jan Gubbels; Boris Striepen; Carlos S Subauste
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

3.  CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon.

Authors:  Carlos S Subauste; Matthew Wessendarp
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 4.  Eating for good health: linking autophagy and phagocytosis in host defense.

Authors:  Miguel A Sanjuan; Douglas R Green
Journal:  Autophagy       Date:  2008-06-03       Impact factor: 16.016

5.  Type II Toxoplasma gondii induction of CD40 on infected macrophages enhances interleukin-12 responses.

Authors:  Pedro Morgado; Dattanand M Sudarshana; Lanny Gov; Katherine S Harker; Tonika Lam; Paolo Casali; Jon P Boyle; Melissa B Lodoen
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

6.  Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha.

Authors:  Hillary D Lum; Ilia N Buhtoiarov; Brian E Schmidt; Gideon Berke; Donna M Paulnock; Paul M Sondel; Alexander L Rakhmilevich
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

7.  A critical role for SOCS3 in innate resistance to Toxoplasma gondii.

Authors:  Ryan J Whitmarsh; Carolyn M Gray; Beth Gregg; David A Christian; Michael J May; Peter J Murray; Christopher A Hunter
Journal:  Cell Host Microbe       Date:  2011-09-15       Impact factor: 21.023

8.  CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.

Authors:  Jose-Andres C Portillo; Luis Muniz Feliciano; Genevieve Okenka; Frederick Heinzel; M Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 9.  Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.

Authors:  Stephen L Rego; Rachel S Helms; Didier Dréau
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 10.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.